Calamos Advisors LLC Decreases Stake in Corteva, Inc. $CTVA

Calamos Advisors LLC reduced its stake in Corteva, Inc. (NYSE:CTVA) by 3.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 162,375 shares of the company’s stock after selling 6,593 shares during the quarter. Calamos Advisors LLC’s holdings in Corteva were worth $10,884,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Fox Run Management L.L.C. increased its holdings in Corteva by 5.1% in the 3rd quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company’s stock worth $227,000 after buying an additional 164 shares during the period. IFG Advisory LLC increased its holdings in Corteva by 1.7% in the 3rd quarter. IFG Advisory LLC now owns 9,764 shares of the company’s stock worth $660,000 after buying an additional 166 shares during the period. Kelleher Financial Advisors increased its holdings in Corteva by 3.8% in the 3rd quarter. Kelleher Financial Advisors now owns 4,594 shares of the company’s stock worth $311,000 after buying an additional 170 shares during the period. Rosenberg Matthew Hamilton increased its holdings in Corteva by 6.1% in the 4th quarter. Rosenberg Matthew Hamilton now owns 2,969 shares of the company’s stock worth $199,000 after buying an additional 172 shares during the period. Finally, United Community Bank increased its holdings in Corteva by 10.5% in the 3rd quarter. United Community Bank now owns 1,849 shares of the company’s stock worth $125,000 after buying an additional 176 shares during the period. Institutional investors and hedge funds own 81.54% of the company’s stock.

Insider Activity at Corteva

In other news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. This trade represents a 50.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.15% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on CTVA. Jefferies Financial Group increased their price target on shares of Corteva from $85.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, March 2nd. Royal Bank Of Canada increased their price target on shares of Corteva from $89.00 to $95.00 and gave the stock an “outperform” rating in a report on Friday. Berenberg Bank increased their price target on shares of Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a report on Thursday, March 26th. Oppenheimer increased their price target on shares of Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a report on Wednesday. Finally, Wolfe Research increased their price target on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $85.19.

Corteva Price Performance

Shares of NYSE CTVA opened at $79.78 on Friday. The stock has a market capitalization of $53.56 billion, a price-to-earnings ratio of 50.50, a PEG ratio of 2.73 and a beta of 0.68. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $85.63. The firm’s 50 day simple moving average is $80.09 and its 200-day simple moving average is $71.64. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting analysts’ consensus estimates of $0.22. The business had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The business’s revenue was down 1.7% on a year-over-year basis. During the same quarter last year, the company earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts expect that Corteva, Inc. will post 3.62 EPS for the current year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 16th. Stockholders of record on Monday, March 2nd were paid a dividend of $0.18 per share. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 45.57%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.